{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:20:40Z","timestamp":1792794040416,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T00:00:00Z","timestamp":1276128000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cervical cancer, caused by specific oncogenic types of human papillomavirus (HPV), is the second most common cancer in women worldwide. A large number of young sexually active women get infected by HPV but only a small fraction of them have persistent infection and develop cervical cancer pointing to co- factors including host genetics that might play a role in outcome of the HPV infection. This study investigated the role of <jats:italic>CCR2-V64I<\/jats:italic> polymorphism in cervical cancer, pre-cancers and HPV infection in South African women resident in Western Cape. <jats:italic>CCR2-V64I<\/jats:italic> polymorphism has been previously reported to influence the progression to cervical cancer in some populations and has also been associated with decreased progression from HIV infection to AIDS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Genotyping for <jats:italic>CCR2-V64I<\/jats:italic> was done by PCR-SSP in a case-control study of 446 women (106 black African and 340 mixed-ancestry) with histologically confirmed invasive cervical cancer and 1432 controls (322 black African and 1110 mixed-ancestry) group-matched (1:3) by age, ethnicity and domicile status. In the control women HPV was detected using the Digene Hybrid Capture II test and cervical disease was detected by cervical cytology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The <jats:italic>CCR2-64I<\/jats:italic> variant was significantly associated with cervical cancer when cases were compared to the control group (P = 0.001). Further analysis comparing selected groups within the controls showed that individuals with abnormal cytology and high grade squamous intraepitleial neoplasia (HSIL) did not have this association when compared to women with normal cytology. HPV infection also showed no association with <jats:italic>CCR2-64I<\/jats:italic> variant. Comparing SIL positive controls with the cases showed a significant association of <jats:italic>CCR2-64I<\/jats:italic> variant (P = 0.001) with cervical cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This is the first study of the role of <jats:italic>CCR2-V64I<\/jats:italic> polymorphism in cervical cancer in an African population. Our results show that <jats:italic>CCR2-64I<\/jats:italic> variant is associated with the risk of cervical cancer but does not affect the susceptibility to HPV infection or HSIL in South African women of black and mixed-ancestry origin. This result implies that the role of CCR2 is important in invasive cancer of the cervix but not in HPV infection or in the development of pre-cancers.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-10-278","type":"journal-article","created":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T06:13:46Z","timestamp":1276236826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women"],"prefix":"10.1186","volume":"10","author":[{"given":"Koushik","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collet","family":"Dandara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lise","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,10]]},"reference":[{"key":"2077_CR1","first-page":"S3","volume-title":"Vaccine","author":"X Castellsague","year":"2007","unstructured":"Castellsague X, Sanjose de S, Aguado T, Louie KS, Bruni L, Munoz J, Diaz M, Irwin K, Gacic M, Beauvais O, Albero G, Ferrer E: HPV and cervical cancer in the world 2007 report. Vaccine. 2007, S3-"},{"key":"2077_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0968-8080(08)32415-X","volume":"16","author":"RI Anorlu","year":"2008","unstructured":"Anorlu RI: Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters. 2008, 16: 41-49. 10.1016\/S0968-8080(08)32415-X.","journal-title":"Reprod Health Matters"},{"key":"2077_CR3","volume-title":"IARC Scientific Publications No 153","author":"DM Parkin","year":"2003","unstructured":"Parkin DM, Ferlay J, Hamdi-Ch\u00e9rif M, Sitas F, Thomas JO, Wabinga H, Whelan SL: Cancer in Africa: Epidemiology and Prevention. IARC Scientific Publications No 153. 2003, Lyon: IARC Press"},{"key":"2077_CR4","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1067\/S0002-9378(03)01079-2","volume":"189","author":"TE Rohan","year":"2003","unstructured":"Rohan TE, Burk RD, Franco EL: Toward a reduction of the global burden of cervical cancer. Am J Obstet Gynecol. 2003, 189: S37-S39. 10.1067\/S0002-9378(03)01079-2.","journal-title":"Am J Obstet Gynecol"},{"key":"2077_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/path.1866","volume":"208","author":"PJ Snijders","year":"2006","unstructured":"Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ: HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol. 2006, 208: 152-164. 10.1002\/path.1866.","journal-title":"J Pathol"},{"key":"2077_CR6","doi-asserted-by":"publisher","first-page":"6766","DOI":"10.1158\/0008-5472.CAN-04-1091","volume":"64","author":"A Kobayashi","year":"2004","unstructured":"Kobayashi A, Greenblatt RM, Anastos K, Minkoff H, Massad LS, Young M, Levine AM, Darragh TM, Weinberg V, Smith Mc-Cune KK: Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res. 2004, 64: 6766-6774. 10.1158\/0008-5472.CAN-04-1091.","journal-title":"Cancer Res"},{"key":"2077_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrc700","volume":"2","author":"RW Tindle","year":"2002","unstructured":"Tindle RW: Immune evasion in human papillomavirus-associated cervical cancer. Nat Rev Cancer. 2002, 2: 59-65. 10.1038\/nrc700.","journal-title":"Nat Rev Cancer"},{"key":"2077_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF03256249","volume":"11","author":"CM Martin","year":"2007","unstructured":"Martin CM, Kehoe L, Spillane CO, O'Leary JJ: Gene discovery in cervical cancer: towards diagnostic and therapeutic biomarkers. Mol Diagn Ther. 2007, 11: 277-290.","journal-title":"Mol Diagn Ther"},{"key":"2077_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/21801","volume":"400","author":"PK Magnusson","year":"1999","unstructured":"Magnusson PK, Sparen P, Gyllensten UB: Genetic link to cervical tumours. Nature. 1999, 400: 29-30. 10.1038\/21801.","journal-title":"Nature"},{"key":"2077_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002, 2: 342-350. 10.1038\/nrc798.","journal-title":"Nat Rev Cancer"},{"key":"2077_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0304-3835(01)00871-0","volume":"179","author":"SJ Um","year":"2002","unstructured":"Um SJ, Rhyu JW, Kim EJ, Jeon KC, Hwang ES, Park JS: Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo. Cancer Lett. 2002, 179: 205-212.","journal-title":"Cancer Lett"},{"key":"2077_CR12","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1084\/jem.186.10.1757","volume":"186","author":"T Kurihara","year":"1997","unstructured":"Kurihara T, Warr G, Loy J, Bravo R: Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med. 1997, 186: 1757-1762. 10.1084\/jem.186.10.1757.","journal-title":"J Exp Med"},{"key":"2077_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/84298","volume":"2","author":"CR MacKay","year":"2001","unstructured":"MacKay CR: Chemokines: immunology's high impact factors. Nat Immunol. 2001, 2: 95-101. 10.1038\/84298.","journal-title":"Nat Immunol"},{"key":"2077_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1359-6101(01)00033-8","volume":"13","author":"AP Vicari","year":"2002","unstructured":"Vicari AP, Caux C: Chemokines in cancer. Cytokine Growth Factor Rev. 2002, 13: 143-154. 10.1016\/S1359-6101(01)00033-8.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2077_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1189\/jlb.1105656","volume":"80","author":"C Lamagna","year":"2006","unstructured":"Lamagna C, urrand-Lions M, Imhof BA: Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol. 2006, 80: 705-713. 10.1189\/jlb.1105656.","journal-title":"J Leukoc Biol"},{"key":"2077_CR16","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1158\/0008-5472.CAN-07-0912","volume":"67","author":"EY Lin","year":"2007","unstructured":"Lin EY, Pollard JW: Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res. 2007, 67: 5064-5066. 10.1158\/0008-5472.CAN-07-0912.","journal-title":"Cancer Res"},{"key":"2077_CR17","first-page":"1469","volume":"149","author":"L Riethdorf","year":"1996","unstructured":"Riethdorf L, Riethdorf S, Gutzlaff K, Prall F, Loning T: Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri. Am J Pathol. 1996, 149: 1469-1476.","journal-title":"Am J Pathol"},{"key":"2077_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<6::AID-IJC2>3.0.CO;2-3","volume":"82","author":"K Kleine-Lowinski","year":"1999","unstructured":"Kleine-Lowinski K, Gillitzer R, Kuhne-Heid R: Monocyte-chemo-attractant-protein-1 (MCP-1)-gene expression in cervical intra-epithelial neoplasias and cervical carcinomas. Int J Cancer. 1999, 82: 6-11. 10.1002\/(SICI)1097-0215(19990702)82:1<6::AID-IJC2>3.0.CO;2-3.","journal-title":"Int J Cancer"},{"key":"2077_CR19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/00002030-200403260-00003","volume":"18","author":"EE Nakayama","year":"2004","unstructured":"Nakayama EE, Tanaka Y, Nagai Y, Iwamoto A, Shioda T: A CCR2-V64I polymorphism affects stability of CCR2A isoform. AIDS. 2004, 18: 729-738. 10.1097\/00002030-200403260-00003.","journal-title":"AIDS"},{"key":"2077_CR20","doi-asserted-by":"publisher","first-page":"782","DOI":"10.7326\/0003-4819-135-9-200111060-00008","volume":"135","author":"JP Ioannidis","year":"2001","unstructured":"Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen G, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, Martinez OP, Meyer L, Michael NL, Operskalski E, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Stewart GJ, Theodorou ID, Ullum H, Vicenzi E, Vlahov D, Wilkinson D, Workman C, et al: Effects of CCR5-Delta32 CCR2-64I and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med. 2001, 135: 782-795.","journal-title":"Ann Intern Med"},{"key":"2077_CR21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.277.5328.959","volume":"277","author":"MW Smith","year":"1997","unstructured":"Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, O'Brien SJ: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS) Multicenter AIDS Cohort Study (MACS) Multicenter Hemophilia Cohort Study (MHCS) San Francisco City Cohort (SFCC) ALIVE Study. Science. 1997, 277: 959-965. 10.1126\/science.277.5328.959.","journal-title":"Science"},{"key":"2077_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00002030-200302140-00012","volume":"17","author":"SA Mulherin","year":"2003","unstructured":"Mulherin SA, O'Brien TR, Ioannidis JP, Goedert JJ, Buchbinder SP, Coutinho RA, Jamieson BD, Meyer L, Michael NL, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Theodorou ID, Vlahov D, Rosenberg PS: Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS. 2003, 17: 377-387. 10.1097\/00002030-200302140-00012.","journal-title":"AIDS"},{"key":"2077_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/viro.1997.8703","volume":"235","author":"RW Doms","year":"1997","unstructured":"Doms RW, Peiper SC: Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology. 1997, 235: 179-190. 10.1006\/viro.1997.8703.","journal-title":"Virology"},{"key":"2077_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jneuroim.2003.09.003","volume":"145","author":"R Miyagishi","year":"2003","unstructured":"Miyagishi R, Niino M, Fukazawa T, Yabe I, Kikuchi S, Tashiro K: C-C chemokine receptor 2 gene polymorphism in Japanese patients with multiple sclerosis. J Neuroimmunol. 2003, 145: 135-138. 10.1016\/j.jneuroim.2003.09.003.","journal-title":"J Neuroimmunol"},{"key":"2077_CR25","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1136\/jmg.2003.013649","volume":"41","author":"A Zafiropoulos","year":"2004","unstructured":"Zafiropoulos A, Crikas N, Passam AM, Spandidos DA: Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J Med Genet. 2004, 41: e59-10.1136\/jmg.2003.013649.","journal-title":"J Med Genet"},{"key":"2077_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000223437","volume":"28","author":"PA Nyquist","year":"2009","unstructured":"Nyquist PA, Winkler CA, McKenzie LM, Yanek LR, Becker LC, Becker DM: Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis. Cerebrovasc Dis. 2009, 28: 124-130. 10.1159\/000223437.","journal-title":"Cerebrovasc Dis"},{"key":"2077_CR27","first-page":"201","volume":"5","author":"MD Omrani","year":"2008","unstructured":"Omrani MD, Mokhtari MR, Tagizadae A, Bagheri M, hmad-Poor P: Association of CCR5-59029 A\/G and CCR2-V64I variants with renal allograft survival. Iran J Immunol. 2008, 5: 201-206.","journal-title":"Iran J Immunol"},{"key":"2077_CR28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000106492","volume":"64","author":"A Coelho","year":"2007","unstructured":"Coelho A, Matos A, Catarino R, Pinto D, Sousa H, Pereira D, Medeiros R: The influence of chemokine receptor CCR2 genotypes in the route to cervical carcinogenesis. Gynecol Obstet Invest. 2007, 64: 208-212.","journal-title":"Gynecol Obstet Invest"},{"key":"2077_CR29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.ygyno.2004.11.028","volume":"96","author":"A Coelho","year":"2005","unstructured":"Coelho A, Matos A, Catarino R, Pinto D, Pereira D, Lopes C, Medeiros R: Protective role of the polymorphism CCR2-64I in the progression from squamous intraepithelial lesions to invasive cervical carcinoma. Gynecol Oncol. 2005, 96: 760-764. 10.1016\/j.ygyno.2004.11.028.","journal-title":"Gynecol Oncol"},{"key":"2077_CR30","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1002\/ijc.22989","volume":"121","author":"EL Ivansson","year":"2007","unstructured":"Ivansson EL, Gustavsson IM, Magnusson JJ, Steiner LL, Magnusson PK, Erlich HA, Gyllensten UB: Variants of chemokine receptor 2 and interleukin 4 receptor but not interleukin 10 or Fas ligand increase risk of cervical cancer. Int J Cancer. 2007, 121: 2451-2457. 10.1002\/ijc.22989.","journal-title":"Int J Cancer"},{"key":"2077_CR31","first-page":"3669","volume":"26","author":"B Zheng","year":"2006","unstructured":"Zheng B, Wiklund F, Gharizadeh B, Sadat M, Gambelunghe G, Hallmans G, Dillner J, Wallin KL, Ghaderi M: Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients. Anticancer Res. 2006, 26: 3669-3674.","journal-title":"Anticancer Res"},{"key":"2077_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/jnci\/89.4.287","volume":"89","author":"A Ahlbom","year":"1997","unstructured":"Ahlbom A, Lichtenstein P, Malmstrom H, Feychting M, Hemminki K, Pedersen NL: Cancer in twins: genetic and nongenetic familial risk factors. J Natl Cancer Inst. 1997, 89: 287-293. 10.1093\/jnci\/89.4.287.","journal-title":"J Natl Cancer Inst"},{"key":"2077_CR33","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/(SICI)1097-0215(19990909)82:6<775::AID-IJC1>3.0.CO;2-V","volume":"82","author":"K Hemminki","year":"1999","unstructured":"Hemminki K, Dong C, Vaittinen P: Familial risks in cervical cancer: is there a hereditary component?. Int J Cancer. 1999, 82: 775-781. 10.1002\/(SICI)1097-0215(19990909)82:6<775::AID-IJC1>3.0.CO;2-V.","journal-title":"Int J Cancer"},{"key":"2077_CR34","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1126\/science.1172257","volume":"324","author":"SA Tishkoff","year":"2009","unstructured":"Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, Froment A, Hirbo JB, Awomoyi AA, Bodo JM, Doumbo O, Ibrahim M, Juma AT, Kotze MJ, Lema G, Moore JH, Mortensen H, Nyambo TB, Omar SA, Powell K, Pretorius GS, Smith MW, Thera MA, Wambebe C, Weber JL, Williams SM: The genetic structure and history of Africans and African Americans. Science. 2009, 324: 1035-1044. 10.1126\/science.1172257.","journal-title":"Science"},{"key":"2077_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1023\/A:1024910808307","volume":"14","author":"S Shapiro","year":"2003","unstructured":"Shapiro S, Rosenberg L, Hoffman M, Kelly JP, Cooper DD, Carrara H, Denny LE, du Toit G, Allan BR, Stander IA, Williamson AL: Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen\/progestogen oral contraceptives (South Africa). Cancer Causes Control. 2003, 14: 485-495. 10.1023\/A:1024910808307.","journal-title":"Cancer Causes Control"},{"key":"2077_CR36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/ije\/dyg081","volume":"32","author":"M Hoffman","year":"2003","unstructured":"Hoffman M, Cooper D, Carrara H, Rosenberg L, Kelly J, Stander I, Williamson AL, Denny L, du Toit G, Shapiro S: Limited Pap screening associated with reduced risk of cervical cancer in South Africa. Int J Epidemiol. 2003, 32: 573-577. 10.1093\/ije\/dyg081.","journal-title":"Int J Epidemiol"},{"key":"2077_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/sj.gene.6363640","volume":"1","author":"J Tang","year":"1999","unstructured":"Tang J, Rivers C, Karita E, Costello C, Allen S, Fultz PN, Schoenbaum EE, Kaslow RA: Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression. Genes Immun. 1999, 1: 20-27. 10.1038\/sj.gene.6363640.","journal-title":"Genes Immun"},{"key":"2077_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0167-5699(92)90008-U","volume":"13","author":"A Mantovani","year":"1992","unstructured":"Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L: The origin and function of tumor-associated macrophages. Immunol Today. 1992, 13: 265-270. 10.1016\/0167-5699(92)90008-U.","journal-title":"Immunol Today"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-278.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-278\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-278.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:12:14Z","timestamp":1630613534000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,10]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2077"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-278","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,10]]},"assertion":[{"value":"29 December 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"278"}}